COMMUNIQUÉS West-GlobeNewswire

La Jolla Pharmaceutical Company Announces Pricing of Public Offering of Common Stock
15/03/2018
SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) (La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients [...]
HempAmericana Issues New Letter to Shareholders
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, Today is 30th day that we have [...]
Checkpoint Therapeutics Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research Annual Meeting
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Actinium Pharmaceuticals to Present at 28th Annual Oppenheimer Healthcare Conference
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM) ("Actinium" or "the Company"), announced today that it will be attending and presenting at the 28 th Annual Oppenheimer [...]
Adaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cells
15/03/2018
PHILADELPHIA and OXFORD, U.K., March 15, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, today reported three partial responses (two confirmed and one [...]
TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced that preclinical data for TG-1601, the Company’s novel BET inhibitor, has been selected for presentation at the [...]
Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update
15/03/2018
- Responses observed in second solid tumor with NY-ESO providing further evidence of the potential of our SPEAR TCR T‑cell therapies to treat solid tumors - - Clinical momentum continues: dosing patients in MAGE-A4 “ [...]
Mustang Bio Announces Key Leadership Appointments
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
FIT Biotech Oy: FIT Biotech's Review of Operations and Financial Statement 2017 published
15/03/2018
FIT Biotech Oy Company announcement, March 15, 2018 at 12:30 EET FIT Biotech's Review of Operations and Financial Statement 2017 published FIT Biotech's Review of Operations and Financial Statement for the year 2017 [...]
Dynavax Announces Acceptance of Two Data Abstracts for SD-101 in Combination with KEYTRUDA® for Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting
15/03/2018
Data from Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Durability Data in Advanced Metastatic Melanoma BERKELEY, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation ( [...]
Vical Reports Fourth Quarter 2017 Financial and Operational Results
15/03/2018
SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today reported financial results for the three months ended December 31, 2017. Net loss for the fourth quarter of 2017 was $3.7 million, [...]
BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema
15/03/2018
RESEARCH TRIANGLE PARK, N.C., March 15, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today the dosing of the first patient into APeX-2, a Phase 3 clinical trial evaluating two dosage [...]
Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017
15/03/2018
NeoCart ® Top-line Phase 3 Clinical Trial Data and Potential Biologics License Application Filing Remain on Track for Third Quarter of 2018 NeoCart Licensing Agreement with MEDINET Co. Ltd. Provides Important Source of [...]
Capital Senior Living Corporation to Present at the 28th Annual Oppenheimer Healthcare Conference on Tuesday, March 20, 2018
15/03/2018
DALLAS , March 15, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, today announced that management will make a [...]
BioAdaptives (OTC PINK: BDPT) Announces New Management
15/03/2018
LAS VEGAS, March 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc., a fully-reporting public company trading under the ticker symbol BDPT (OTC PINK:BDPT) announced that Mr. Kim D. Southworth has assumed the position of [...]
AC Immune prepares for a first in human study of a promising positron emission tomography (PET) tracer for Parkinson's disease
15/03/2018
First potential PET tracer for Parkinson's disease First in human study is scheduled for the second half of 2018 AC Immune's lead compound is highly selective for alpha-synuclein - a key protein in Parkinson's disease [...]
Affimed to Present Data on AFM24 at AACR Annual Meeting 2018
15/03/2018
Heidelberg, Germany, March 15, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today the [...]
LIDDS: NanoZolid® with cutting edge STING agonist becomes a key project for LIDDS in immuno-oncology field
15/03/2018
Single intratumoral injections of a NanoZolid formulated STING agonist has been proven to achieve significant effects on tumor growth reduction and overall survival. These positive effects of the NanoZolid formulation [...]
Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel
15/03/2018
VANCOUVER, British Columbia, March 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) ( “ Veritas ” or the “Company”) is pleased to announce that Justin Kausel has joined the [...]

Pages